Application no. and date | 17807900.0 (espacenet) (Federated) (European Patent Register), 20171122 | Patent/reg. no. and date | DK/EP 3544981, 20210623 | Publication date | 20191002 | Priority no. and date | GB 201619694, 20161122 | EP pub. no. and date |
EP 3544981 20191002 | Effective date | | Applicant/owner | Enterprise Therapeutics Limited, Sussex Innovation Centre University of Sussex Science Park Square
Falmer, Brighton BN1 9SB, GB | Applicant ref. no. | 164831/BT/MC | Inventor | MCCARTHY, Clive, c/o Enterprise Therapeutics Limited Sussex Innovation Centre University of Sussex Science Park Square Falmer
Brighton Sussex BN1 9SB, GB, WENT, Naomi, Evotec (UK) Limited 114 Innovation Drive Milton Park
Abingdon Oxfordshire OX14 4RZ, GB, HARGRAVE, Jonathan, David, Evotec (UK) Limited 114 Innovation Drive Milton Park
Abingdon Oxfordshire OX14 4RZ, GB, HAY, Duncan, Alexander, Evotec (UK) Limited 114 Innovation Drive Milton Park
Abingdon Oxfordshire OX14 4RZ, GB, SCHOFIELD, Thomas, Beauregard, Evotec (UK) Limited 114 Innovation Drive Milton Park
Abingdon Oxfordshire OX14 4RZ, GB | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/4985 (2006.01) , A61P 11/12 (2006.01) , C07D 487/04 (2006.01) | Title | BENZODIAZOLIUMFORBINDELSER SOM ENAC-INHIBITORER | Int. application no. | GB2017053499 | Int. publication no. | WO2018096325 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|